Morgan Stanley Thermo Genesis Holdings, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$0.28 - $0.67 $61 - $147	-220 Reduced 2.83%	7,545 $2,000
Q2 2022 Aug 15, 2022	SELL	$0.28 - $0.67 $61 - $147	-220 Reduced 2.83%	7,545 $2,000
Q1 2022 Oct 27, 2022	BUY	$0.54 - $1.11 $118 - $244	220 Added 2.92%	7,765 $5,000
Q1 2022 May 13, 2022	BUY	$0.54 - $1.11 $7 - $14	13 Added 0.17%	7,765 $5,000
Q4 2021 Feb 14, 2022	SELL	$1.01 - $2.03 $175 - $353	-174 Reduced 2.2%	7,752 $8,000
Q3 2021 Nov 15, 2021	BUY	$1.97 - $2.67 $15,614 - $21,162	7,926 New	7,926 $16,000

Ticker THMO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,321,400
Description
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.